Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Income towards Parent Company: 2011-2024

Historic Income towards Parent Company for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $421,000.

  • Mimedx Group's Income towards Parent Company rose 7617.97% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year increase of 1464.25%. This contributed to the annual value of $421,000 for FY2024, which is 104.57% up from last year.
  • Mimedx Group's Income towards Parent Company amounted to $421,000 in FY2024, which was up 104.57% from -$9.2 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Income towards Parent Company registered a high of $2.0 million during FY2021, and its lowest value of -$49.3 million during FY2020.
  • In the last 3 years, Mimedx Group's Income towards Parent Company had a median value of -$9.2 million in 2023 and averaged -$6.3 million.
  • In the last 5 years, Mimedx Group's Income towards Parent Company plummeted by 608.13% in 2022 and then soared by 104.57% in 2024.
  • Yearly analysis of 5 years shows Mimedx Group's Income towards Parent Company stood at -$49.3 million in 2020, then spiked by 104.09% to $2.0 million in 2021, then plummeted by 608.13% to -$10.2 million in 2022, then rose by 10.08% to -$9.2 million in 2023, then surged by 104.57% to $421,000 in 2024.